Vytrus Biotech S.A. Defensive Interval Ratio
Vytrus Biotech S.A. defensive interval ratio. Vytrus Biotech S.A. (VYT) has a Defensive Interval Ratio of 202 days as of December 2025. Defensive assets of €982.61K (cash €-, short-term investments €600.00, receivables €982.01K) cover 202 days of daily cash needs of €4.87K/day. See Vytrus Biotech S.A. (VYT) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Vytrus Biotech S.A. (2020–2025)
Defensive interval ratio of Vytrus Biotech S.A. from 2020 to 2025. This chart shows how Vytrus Biotech S.A.'s Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 202 days, meaning defensive assets of €982.61K can fund 202 days of operations without new revenue. Check asset resilience ratio of Vytrus Biotech S.A. to evaluate the company's liquid asset resilience ratio.
Vytrus Biotech S.A. Defensive Interval Ratio by Year (2020–2025)
Vytrus Biotech S.A. defensive interval ratio by year from 2020 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Vytrus Biotech S.A. from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Vytrus Biotech S.A. asset portfolio.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 202 days | €982.61K | €4.87K/day | €- | €600.00 | ▲ +22 days |
| 2024 | 180 days | €618.39K | €3.43K/day | €- | €600.00 | ▼ -22 days |
| 2023 | 202 days | €550.86K | €2.73K/day | €- | €600.00 | ▲ +76 days |
| 2022 | 126 days | €436.31K | €3.48K/day | €- | €- | ▲ +30 days |
| 2021 | 96 days | €211.64K | €2.21K/day | €- | €520.00 | ▼ -13 days |
| 2020 | 109 days | €192.46K | €1.76K/day | €- | €740.00 | — |